Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (421-430 of 521) with videos related to

Pageof 53
Sort By:
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.
Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.
American Journal of Clinical Oncology|December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II studySana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.
Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancersB F El-Rayes, M Zalupski, T Bekai-Saab, et al.
Science Advances|January 17, 2025
Viroporin activity is necessary for intercellular calcium signals that contribute to viral pathogenesisJ Thomas Gebert, Francesca J Scribano, Kristen A Engevik, et al.
Surgery|September 5, 2012
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101Aamer M Qazi, Oksana Gruzdyn, Assaad Semaan, et al.
Pageof 53

Showing results (421-430 of 521) with videos related to

Sort By:
Pageof 53
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.
Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.
American Journal of Clinical Oncology|December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II studySana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.
Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancersB F El-Rayes, M Zalupski, T Bekai-Saab, et al.
Science Advances|January 17, 2025
Viroporin activity is necessary for intercellular calcium signals that contribute to viral pathogenesisJ Thomas Gebert, Francesca J Scribano, Kristen A Engevik, et al.
Surgery|September 5, 2012
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101Aamer M Qazi, Oksana Gruzdyn, Assaad Semaan, et al.
Pageof 53